MERZ PHARMACEUTICALS GMBH
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1908-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.radiesse.de
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
- Conditions
- Moderate to Severe Glabellar Frown Lines
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-10-09
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 271
- Registration Number
- NCT00770211
- Locations
- 🇺🇸
About Skin Dermatoloy, Englewood, Colorado, United States
🇺🇸Laser & Skin Surgery Center of Indiana, Carmel, Indiana, United States
🇺🇸Frederic Brandt, Coral Gables, Florida, United States
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2
- Conditions
- Moderate to Severe Glabellar Frown Lines
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-10-09
- Last Posted Date
- 2013-02-27
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 276
- Registration Number
- NCT00770029
- Locations
- 🇺🇸
Flynn Consulting PLLC, Raleigh, North Carolina, United States
🇺🇸Skin Care Center, Los Angeles, California, United States
🇺🇸Coleman William, Meatrie, Louisiana, United States
Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2016-02-04
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 411
- Registration Number
- NCT00739635
- Locations
- 🇬🇧
The Horsley Medical Practice, East Horsley, Leatherhead, Surrey, United Kingdom
🇪🇸Hospital Universitario PrÃncipe de Asturias, Madrid, Spain
🇩🇪HNO-Praxis im Gesundheitszentrum Walsum, Duisburg, Germany
Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers
- First Posted Date
- 2008-07-09
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 64
- Registration Number
- NCT00712283
- Locations
- 🇩🇪
Merz Pharmaceuticals, Frankfurt/Main, Germany
Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
- Conditions
- Healthy
- First Posted Date
- 2008-06-10
- Last Posted Date
- 2012-10-30
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 108
- Registration Number
- NCT00694148
- Locations
- 🇩🇪
Dr. Matthias Imhof, Medico Palais Bad Soden, Bad Soden, Hessen, Germany
Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus
- Conditions
- Nystagmus, Congenital IdiopathicNystagmus, Acquired
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2009-11-26
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT00661440
- Locations
- 🇬🇧
University of Leicester, Leicester Royal Infirmary, Ophthalmology Group, Leicester, United Kingdom
Memantine and Antipsychotics Use
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2011-09-26
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 19
- Registration Number
- NCT00649220
- Locations
- 🇩🇪
Alexianer Hospital, Krefeld, North-Rhine-Westphalia, Germany
Memantine - Communication Study
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: Memantine-HCl
- First Posted Date
- 2008-02-26
- Last Posted Date
- 2011-11-01
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 107
- Registration Number
- NCT00624026
- Locations
- 🇩🇪
Central Medical Affairs, Frankfurt/Main, Germany
Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles
- Conditions
- Lateral Periorbital Wrinkles
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 111
- Registration Number
- NCT00541723
Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 82
- Registration Number
- NCT00541905
- Locations
- 🇩🇪
Medizinische Hochschule Hannover (LKP), Hannover, Germany